Avid Bioservices Company Leadership
| CDMO Stock | USD 12.49 0.01 0.08% |
Avid Bioservices employs about 371 people. The company is managed by 10 executives with a total tenure of roughly 27 years, averaging almost 2.0 years of service per executive, having 37.1 employees per reported executive. Analysis of Avid Bioservices' management performance can provide insight into the firm performance.
| Shelley Fussey President Vice President - Intellectual Property |
Avid |
Avid Bioservices Management Team Effectiveness
The company has return on total asset (ROA) of (0.0305) % which means that it has lost $0.0305 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.1584) %, meaning that it created substantial loss on money invested by shareholders. Avid Bioservices' management efficiency ratios could be used to measure how well Avid Bioservices manages its routine affairs as well as how well it operates its assets and liabilities.Avid Bioservices Workforce Comparison
Avid Bioservices is rated fourth in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 4,773. Avid Bioservices holds roughly 371 in number of employees claiming about 8% of equities under Health Care industry.
The company has Profit Margin (PM) of (1.01) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.06) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.06. Avid Bioservices Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Avid Bioservices insiders, such as employees or executives, is commonly permitted as long as it does not rely on Avid Bioservices' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Avid Bioservices insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Avid Bioservices Notable Stakeholders
An Avid Bioservices stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Avid Bioservices often face trade-offs trying to please all of them. Avid Bioservices' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Avid Bioservices' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Shelley Fussey | Vice President - Intellectual Property | Profile | |
| Mark JD | General VP | Profile | |
| Daniel Hart | Chief Officer | Profile | |
| Oksana Lukash | Vice People | Profile | |
| Prof Brekken | Medical Advisor | Profile | |
| Harold MD | Medical Advisor | Profile | |
| Prof Schroit | Medical Advisor | Profile | |
| Matthew Kwietniak | Chief Officer | Profile | |
| Richard Richieri | Chief Officer | Profile | |
| Tracy Kinjerski | VP Operations | Profile |
About Avid Bioservices Management Performance
The success or failure of an entity such as Avid Bioservices often depends on how effective the management is. Avid Bioservices management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Avid management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Avid management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. Avid Bioservices, Inc. was incorporated in 1981 and is headquartered in Tustin, California. Avid Bioservices operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 321 people.
Avid Bioservices Workforce Analysis
Traditionally, organizations such as Avid Bioservices use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Avid Bioservices within its industry.Avid Bioservices Manpower Efficiency
Return on Avid Bioservices Manpower
| Revenue Per Employee | 377.1K | |
| Revenue Per Executive | 14M | |
| Net Loss Per Employee | 379.4K | |
| Net Loss Per Executive | 14.1M | |
| Working Capital Per Employee | 90.1K | |
| Working Capital Per Executive | 3.3M |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avid Bioservices. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population. To learn how to invest in Avid Stock, please use our How to Invest in Avid Bioservices guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avid Bioservices. If investors know Avid will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avid Bioservices listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Avid Bioservices is measured differently than its book value, which is the value of Avid that is recorded on the company's balance sheet. Investors also form their own opinion of Avid Bioservices' value that differs from its market value or its book value, called intrinsic value, which is Avid Bioservices' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avid Bioservices' market value can be influenced by many factors that don't directly affect Avid Bioservices' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avid Bioservices' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avid Bioservices is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avid Bioservices' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.